Policy ForumSCIENCE AND REGULATION

Probiotics: Finding the Right Regulatory Balance

Science  18 Oct 2013:
Vol. 342, Issue 6156, pp. 314-315
DOI: 10.1126/science.1244656

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


This article has a correction. Please see:

Summary

Initial findings of the Human Microbiome Project (HMP), funded by the U.S. National Institutes of Health (NIH), raise important questions about the role and variation of microorganisms within individuals and across populations (1). One related area of growing research and commercial interest is the development and use of probiotics, substances containing live microorganisms that have a beneficial effect when taken in sufficient quantities (2) and “designed to intentionally manipulate microbiome and host properties” (3). We offer observations about the regulatory process for probiotics and potential areas for reform.

Related Content